<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02696733</url>
  </required_header>
  <id_info>
    <org_study_id>U/1/2014</org_study_id>
    <nct_id>NCT02696733</nct_id>
  </id_info>
  <brief_title>Ultrasound-Guided ONB for Transurethral Procedures - Interadductor Approach</brief_title>
  <official_title>Ultrasound-Guided Obturator Nerve Block for Transurethral Procedures - Interadductor Approach</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Warsaw</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Warsaw</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Obturator nerve block is an effective method to prevent adductor muscles contraction during
      transurethral resection of bladder tumour localized on the lateral wall. Due to prior spinal
      anaesthesia the patient does not feel uncomfortable during the blockade and the interadductor
      approach gives the possibility to perform it in the lithotomy position. The aim of the study
      was to evaluate the safety and effectiveness of ultrasound-guided obturator nerve
      identification and blockade for TURBT.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The basic methods for diagnosis and management of bladder cancer are endoscopic procedures.
      Transurethral resection of bladder tumor (TURBT) is usually performed under spinal anesthesia
      that does not prevent an unintended stimulation of the obturator nerve (ON) when
      electroresection is performed on the lateral wall of the bladder. This sensorimotor nerve
      arises from the lumbar plexus at L2-L4. It innervates the muscles responsible for adducting
      the thigh and the skin on the surface of the paramedian segment of the thigh. During TURBT,
      when the bladder has been filled with irrigation fluid, the ON is directly adjacent to the
      lateral wall of the bladder and it can be stimulated during the electroresection. Sudden
      contraction of the adductor muscles of the thigh, may lead to perforation of bladder wall
      with the resectoscope loop.

      In the Department of General, Oncologic and Functional Urology, Medical University of Warsaw
      approximately 500 TURBT are performed every year; 7% of them necessitate the prevention of ON
      stimulation. Anesthetists perform obturator nerve block (ONB) - the anterior branch, using
      the stimulator for the identification with the 94% efficacy.

      Recently, ultrasound guidance has been used to enhance the safety and efficacy of the nerve
      blocks that is why we have decided to evaluate the effectiveness of ONB performed with
      ultrasounds.

      An approval from the Medical University of Warsaw Bioethical Committee has been obtained.
      Patients need to give written informed consent to participate in the study.

      It is anticipated that 100 patients with TURBT performed under spinal anesthesia that, after
      the urologist decision, necessitate the ONB will be enrolled in this study.

      Before the procedure an oral premedication is given. After admission to the operating room,
      intravenous access is established and the patient receives a drip infusion of 500 ml 0.9%
      Natrium Chloratum with an antibiotic (2nd generation cephalosporin). Constant monitoring is
      ensured of ECG, heart rate, and pulse oxymetry. Non-invasive blood pressure measurement is
      taken every five minutes. To maintain patients' blood oxygenation, oxygen is delivered with
      the use of a facemask. Spinal anesthesia is performed with patients in the sitting position,
      most frequently in the L3 L4 space (in the case of technical difficulties - L2 L3 or L4 L5)
      using 8-15 mg 0.5% hyperbaric bupivacaine depending on the patient's anthropometric
      parameters. The needles used are 25-27G pencil point. After drug administration, the patient
      is placed in the supine position.

      Upon reaching the appropriate anesthesia level (Th10), which blocks conduction in the sensory
      nerve fibers of the bladder, the patient is placed in the lithotomy position. In the case of
      tumors located on the lateral wall of the bladder, the safety of TURBT is ensured using a
      neurotest performed by an urologist with a nerve stimulator built into the resectoscope
      (Neurotester FB2, ERBE). The extremity movement leads to the decision to block the ON.

      Ultrasound-guided ONB procedure:

      The patient remains in the lithotomy position. For nerve identification a linear transducer
      is used. It is placed next to the grain to visualize three adductor muscles. Between adductor
      longus and adductor brevis, in fascial plane, an anterior branch of obturator should be
      visualized. The needle is advanced toward the nerve in an out-of-plane trajectory. The local
      anesthetic is injected after heme-negative aspiration. The resistance during injection is
      avoided to reduce the risk of intraneural injection. If there are problems with nerve
      identification the anesthetic is injected in fascial plane between adductors muscles - longus
      and brevis.

      10 ml of 2% lidocaine is used for single block and 2 x 10 ml of 2% lidocaine with epinephrine
      when bilateral one is needed.

      Before TURBT starts again, the urologist once more perform the neurotest to evaluate the ONB
      efficacy.

      After enrolling 50 patients to the study the results will be evaluated and the decision
      whether to decrease the amount of 10 ml of 2% lidocaine for injection will be taken.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2016</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effectiveness of ultrasound guided obturator nerve block - evaluated by a number of participants having transurethral resection of bladder tumor without unintended obturator nerve stimulation.</measure>
    <time_frame>30 months</time_frame>
    <description>The investigator evaluates whether the urologist was able to perform safe electroresection of bladder tumor with no extremity movement. All extremity movements due to obturator nerve stimulation and all necessities to perform general anesthesia will be counted as unsuccessful ultrasound - guided ONB.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Success rate of obturator nerve visualization with ultrasounds</measure>
    <time_frame>30 months</time_frame>
    <description>The investigators evaluate whether it was possible to visualize the obturator nerve in the fascial plane</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Efficacy of ONB - measured with nerve stimulator built in the resectoscope</measure>
    <time_frame>30 months</time_frame>
    <description>A nerve stimulator (Neurotester FB2, ERBE) is used to evaluate the efficacy of the nerve block. Current flow settings are progressively marked relative to a 1-5 scale .</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety of ultrasound-guided ONB measured by number of complications</measure>
    <time_frame>30 months</time_frame>
    <description>hematoma , lidocaine overdose symptoms, bladder perforation,obturator nerve injury</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Urinary Bladder Neoplasms</condition>
  <condition>Transurethral Resection</condition>
  <condition>Nerve Block</condition>
  <arm_group>
    <arm_group_label>UG - ONB</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with the bladder tumor located on the lateral wall, with the high risk of adductor muscles contraction during TURBT under spinal anesthesia.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ultrasound</intervention_name>
    <description>Ultrasound-guided obturator nerve localization</description>
    <arm_group_label>UG - ONB</arm_group_label>
    <other_name>USG</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>lidocaine 2%</intervention_name>
    <description>local anesthetic used to block the obturator nerve</description>
    <arm_group_label>UG - ONB</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.9% Natrium Chloratum with a 2nd generation cephalosporin</intervention_name>
    <arm_group_label>UG - ONB</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  informed consent

          -  bladder tumor located on the lateral wall

          -  transurethral resection of the bladder tumor

          -  urologist decision that there is a risk of the stimulation of obturator nerve during
             resection

          -  spinal anesthesia

        Exclusion Criteria:

          -  patients' refusal

          -  contraindications for spinal anesthesia

          -  skin lesions at injection site

          -  patients who really did not need ONB.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Karolina Dobronska, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>I Department of Anaesthesiology and Intensive Care</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Karolina Dobronska, MD</last_name>
    <phone>+48 22 502 17 27</phone>
    <email>karolinapladzyk@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lidia I Jureczko, PhD MD</last_name>
    <phone>+48 22 502 17 27</phone>
    <email>jureczko@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>I Department od Anaesthesiology and Intensive Care</name>
      <address>
        <city>Warsaw</city>
        <zip>02-005</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karolina Dobronska, MD</last_name>
      <phone>+48 22 501 17 27</phone>
      <email>karolinapladzyk@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Lidia I Jureczko, PhD MD</last_name>
      <phone>+48 22 501 17 27</phone>
      <email>jureczko@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Karolina Dobronska, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lidia I Jureczko, PhD MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>I Department of Anaesthesiology and Intensive Care, Medical University of Warsaw</name>
      <address>
        <city>Warsaw</city>
        <zip>02-005</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karolina Dobronska, MD</last_name>
      <phone>+48 22 501 17 27</phone>
      <email>karolinapladzyk@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Lidia I Jureczko, PhD MD</last_name>
      <phone>+48 22 501 17 27</phone>
      <email>jureczko@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Karolina Dobronska, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lidia I Jureczko, PhD MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <reference>
    <citation>Pladzyk K, Jureczko L, Lazowski T. Over 500 obturator nerve blocks in the lithotomy position during transurethral resection of bladder tumor. Cent European J Urol. 2012;65(2):67-70. doi: 10.5173/ceju.2012.02.art2. Epub 2012 Jun 12.</citation>
    <PMID>24578931</PMID>
  </reference>
  <results_reference>
    <citation>Thallaj A, Rabah D. Efficacy of ultrasound-guided obturator nerve block in transurethral surgery. Saudi J Anaesth. 2011 Jan;5(1):42-4. doi: 10.4103/1658-354X.76507.</citation>
    <PMID>21655015</PMID>
  </results_reference>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 22, 2016</study_first_submitted>
  <study_first_submitted_qc>March 1, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 2, 2016</study_first_posted>
  <last_update_submitted>July 13, 2017</last_update_submitted>
  <last_update_submitted_qc>July 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 18, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Warsaw</investigator_affiliation>
    <investigator_full_name>Karolina Dobro≈Ñska</investigator_full_name>
    <investigator_title>M.D.</investigator_title>
  </responsible_party>
  <keyword>TURBT</keyword>
  <keyword>ultrasound guided</keyword>
  <keyword>ONB</keyword>
  <keyword>interadductor approach</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Bladder Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Cephalosporins</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

